Molina Healthcare, Inc (NYSE:MOH) Receives Average Rating of “Hold” from Brokerages

Molina Healthcare, Inc (NYSE:MOH) has been given a consensus recommendation of “Hold” by the fourteen research firms that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $157.8571.

A number of analysts have commented on the stock. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $224.00 target price on shares of Molina Healthcare in a report on Tuesday, January 6th. TD Cowen decreased their target price on Molina Healthcare from $175.00 to $144.00 and set a “hold” rating on the stock in a report on Monday, February 9th. UBS Group reiterated a “neutral” rating and set a $145.00 target price on shares of Molina Healthcare in a research report on Monday, February 9th. Mizuho set a $220.00 price target on Molina Healthcare in a research report on Friday, January 9th. Finally, Wells Fargo & Company set a $141.00 price objective on Molina Healthcare and gave the stock an “equal weight” rating in a research note on Friday.

Molina Healthcare Trading Up 3.7%

MOH opened at $156.53 on Tuesday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.97. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $359.97. The stock has a market cap of $8.06 billion, a PE ratio of 18.29 and a beta of 0.49. The business has a 50 day moving average of $168.95 and a 200-day moving average of $169.01.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). The business had revenue of $11.38 billion for the quarter, compared to the consensus estimate of $10.90 billion. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The company’s revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the firm earned $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities research analysts predict that Molina Healthcare will post 24.4 earnings per share for the current fiscal year.

Institutional Trading of Molina Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. AQR Capital Management LLC raised its holdings in Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after acquiring an additional 2,008,458 shares during the period. 8 Knots Management LLC purchased a new stake in shares of Molina Healthcare during the fourth quarter worth about $198,942,000. Victory Capital Management Inc. raised its stake in Molina Healthcare by 344.3% during the 3rd quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock valued at $184,380,000 after purchasing an additional 746,639 shares during the period. Norges Bank bought a new stake in Molina Healthcare during the 2nd quarter valued at approximately $212,113,000. Finally, Madison Avenue Partners LP purchased a new position in Molina Healthcare in the 4th quarter worth approximately $110,003,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.